Your browser doesn't support javascript.
loading
Atezolizumab With Neoadjuvant Anti-Human Epidermal Growth Factor Receptor 2 Therapy and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Primary Results of the Randomized Phase III IMpassion050 Trial.
Huober, Jens; Barrios, Carlos H; Niikura, Naoki; Jarzab, Michal; Chang, Yuan-Ching; Huggins-Puhalla, Shannon L; Pedrini, José; Zhukova, Lyudmila; Graupner, Vilma; Eiger, Daniel; Henschel, Volkmar; Gochitashvili, Nino; Lambertini, Chiara; Restuccia, Eleonora; Zhang, Hong.
Afiliação
  • Huober J; Cantonal Hospital, Breast Center St Gallen, St Gallen, Switzerland.
  • Barrios CH; University Hospital, Ulm, Germany.
  • Niikura N; Centro de Pesquisa em Oncologia, Hospital São Lucas, PUCRS, Porto Alegre, Brazil.
  • Jarzab M; Department of Breast Oncology, Tokai University School of Medicine, Isehara, Japan.
  • Chang YC; Breast Cancer Unit, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
  • Huggins-Puhalla SL; Department of Surgery, Mackay Memorial Hospital, Taipei, Taiwan.
  • Pedrini J; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA.
  • Zhukova L; Hospital Nossa Senhora da Conceição, Porto Alegre, Brazil.
  • Graupner V; SBIH Moscow Clinical Scientific and Practical Center named after A.S. Loginov of DHM, Moscow, Russia.
  • Eiger D; Product Development Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Henschel V; Product Development Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Gochitashvili N; Product Development Data Science, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Lambertini C; Product Development Safety, Roche Products Limited, Welwyn Garden City, United Kingdom.
  • Restuccia E; Oncology Biomarker Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Zhang H; Product Development Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
J Clin Oncol ; 40(25): 2946-2956, 2022 09 01.
Article em En | MEDLINE | ID: mdl-35763704

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante Tipo de estudo: Clinical_trials Limite: Female / Humans Idioma: En Revista: J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça